About this Journal Submit a Manuscript Table of Contents

Assessment and Incorporation of Health Technology for Tuberculosis Control in the Context of HIV

Call for Papers

Tuberculosis (TB) remains a major killer worldwide, especially when associated with HIV/AIDS. Resistance to highly effective drugs is a threat for both epidemics to control. The United Nations has set, among other Millennium Development Goals, an initiative to halt and begin to reverse the incidence rates of TB and HIV/AIDS by 2015. In the last decade, after a century of stagnation, new preventive, diagnostic, and therapeutic technologies have been developed for TB control.

These new technologies need to be evaluated regarding their efficacy, effectiveness, safety, cost-effectiveness, and feasibility. Once the decision for technology adoption is made, their implementation needs to be planned by the National Tuberculosis and HIV Programs. Health system interactions between both programs are necessary for appropriate control of the diseases in countries with high incidence of coinfection.

This special issue of the journal focuses on the prevention, diagnosis, treatment, and control of tuberculosis in the context of HIV/AIDS. Articles are sought that provide evidence on the opportunities, limitations, and consequences of new diagnostics, new drugs, and population-based interventions of TB in persons living with HIV/AIDS. Potential topics include, but are not limited to:

  • Point-of-care and other new tests for TB in the context of HIV
  • Biomarkers of risk for developing active TB and cure of infection
  • Vaccines for TB: prospects in high-HIV prevalence settings
  • Communication/information health system technologies
  • New treatment regimens for latent TB infection
  • New treatment regimens for active sensitive and resistant TB
  • Interactions between drugs to treat TB and HIV/AIDS
  • Directly observed therapy, access to health services, and barriers to the health system
  • Modeling for epidemiologic impact analysis of technology incorporation
  • Population-based interventions to improve TB care in HIV-infected populations
  • Feasibility of adoption of new technologies for TB/HIV in developing countries

Authors are invited to submit original and review articles.

Before submission authors should carefully review the journal’s Author Guidelines, which is located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at: http://mts.hindawi.com/submit/journals/bmri/infectious.diseases/tubai/ according to the following timetable:

Manuscript DueFriday, 31 January 2014
First Round of ReviewsFriday, 25 April 2014
Publication DateFriday, 20 June 2014

Lead Guest Editor

  • Anete Trajman, Health Education Post-Graduation Program, Gama Filho University, Rio de Janeiro, RJ, Brazil

Guest Editors

  • Dick Menzies, Montreal Chest Institute, Professor of Epidemiology and Biostatistics, Montreal, PQ, Canada
  • Frank Cobelens, AIGHD Foundation and Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam , The Netherlands
  • Ilesh Jani, Instituto Nacional de Saúde, Ministry of Health, Maputo, Mozambique